Clindamycin USP 600mg/4ml Injection.
Clindamycin is indicated in the treatment of the following infections casued by susceptible anaerobic bacteria or susceptible strains of gram positive bacteria such as streptococci, Pneumococci and staphylococci in Lower respiratory tract infections, skin and soft tissue infections, Bone and joint infections, Septicemia, Dental infections and also indicated for the treatment of AIDS associated Pneumonia.
Clindamycin USP 600mg/4ml Injection.
Clindamycin is indicated in the treatment of the following infections casued by susceptible anaerobic bacteria or susceptible strains of gram positive bacteria such as streptococci, Pneumococci and staphylococci in Lower respiratory tract infections, skin and soft tissue infections, Bone and joint infections, Septicemia, Dental infections and also indicated for the treatment of AIDS associated Pneumonia.
Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.